Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2020

Open Access 01-12-2020 | Research article

A scoping review of cohort studies assessing traditional Chinese medicine interventions

Authors: Yuting Duan, Zhirui Xu, Jingjing Deng, Yanjia Lin, Yan Zheng, Juexuan Chen, Xiaoyu Tang, Xuan Zhang, Chunzhi Tang, Jiangxia Miao, Zhaoxiang Bian

Published in: BMC Complementary Medicine and Therapies | Issue 1/2020

Login to get access

Abstract

Backgrounds

Identifying topics and assessing the reporting quality of Traditional Chinese Medicine (TCM) cohort studies.

Methods

A scoping review of the literature was performed. A descriptive approach to summarize the core study characteristics was prepared, along with structured tables and figures to identify salient points of differences noted across studies. The reporting quality of TCM cohort studies was assessed according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)-cohort checklist.

Results

A total of 199 TCM cohort studies were included. The largest number of TCM cohort studies was conducted in Mainland China (70.9%). The TCM cohort study was first published in 2003. The top three diseases studied were Acquired Immune Deficiency Syndrome (AIDS), Stroke, and Asthma. As for the intervention methods, Chinese herbal medicine formulas (60.3%), acupuncture (14.1%) and single herbs (12.6%) accounted for the majority, followed by moxibustion (4.0%) and qigong (2.0%). The overage sufficient reporting rate of included TCM cohort studies according to the STROBE-cohort checklist was 42.9%. Comparing with Chinese literature, the reporting rates of English literature in most items were higher.

Conclusion

For the application of cohort studies to inform the effects of TCM interventions, the interventions assessed and conditions studied were diverse, the reporting quality was unsatisfied.
Appendix
Available only for authorised users
Literature
2.
go back to reference Xing J, Fei Y, Chen W, et al. Application of observational studies in clinical research of traditional Chinese medicine (1) ——cohort study method and design. J Tradit Chin Med. 2008;49(6):502–3 (in Chinese). Xing J, Fei Y, Chen W, et al. Application of observational studies in clinical research of traditional Chinese medicine (1) ——cohort study method and design. J Tradit Chin Med. 2008;49(6):502–3 (in Chinese).
12.
go back to reference Wang H, Bi H, Zhen H, et al. Pharmacoeconomic evaluation of huoxue zhitong soft capsule in the treatment of soft tissue injury. Chin J Drug Eval. 2017;34(4):309–13 (in Chinese). Wang H, Bi H, Zhen H, et al. Pharmacoeconomic evaluation of huoxue zhitong soft capsule in the treatment of soft tissue injury. Chin J Drug Eval. 2017;34(4):309–13 (in Chinese).
13.
go back to reference Meng S, Gong T, Ouyang H, et al. Pharmacoeconomic evaluation of getone tongluo capsule in the treatment of ischemic stroke. China J Pharm Econ. 2019;14(4):23–9 (in Chinese). Meng S, Gong T, Ouyang H, et al. Pharmacoeconomic evaluation of getone tongluo capsule in the treatment of ischemic stroke. China J Pharm Econ. 2019;14(4):23–9 (in Chinese).
Metadata
Title
A scoping review of cohort studies assessing traditional Chinese medicine interventions
Authors
Yuting Duan
Zhirui Xu
Jingjing Deng
Yanjia Lin
Yan Zheng
Juexuan Chen
Xiaoyu Tang
Xuan Zhang
Chunzhi Tang
Jiangxia Miao
Zhaoxiang Bian
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2020
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-020-03150-9

Other articles of this Issue 1/2020

BMC Complementary Medicine and Therapies 1/2020 Go to the issue